Rani Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results; Provides Corporate Update

Go back to Rani Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results; Provides Corporate Update

Rani Therapeutics Holdings, Inc. (RANI) Misses Q4 EPS by 1c

March 31, 2025 4:07 PM EDT

Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) reported Q4 EPS of ($0.27), $0.01 worse than the analyst estimate of ($0.26).

For earnings history and earnings-related data on Rani Therapeutics Holdings, Inc. (RANI) click here.

... More